Volcano Corp (NASDAQ:VOLC)

CAPS Rating: 2 out of 5

The Company is engages in the development, manufacture and commercialization of intravascular ultrasound and functional measurement products that are used for the diagnosis and treatment of vascular and structural heart disease.

Recs

0
Player Avatar Smitter11 (< 20) Submitted: 11/30/2011 5:38:09 PM : Outperform Start Price: $24.75 VOLC Score: +10.11

This is a company with unique technology in a growing market. They are preparing for expansion and will easily outperform the market for the next 2-3 years.

Featured Broker Partners


Advertisement